System and methods for performing saliva-based diagnostic screenings
US-2024420847-A1 · Dec 19, 2024 · US
US12480948B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12480948-B2 |
| Application number | US-202217856052-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 1, 2022 |
| Priority date | Apr 25, 2022 |
| Publication date | Nov 25, 2025 |
| Grant date | Nov 25, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a ratiometric fluorescent probe for detecting aminopeptidase N, and a preparation method and use thereof. In the present disclosure, a Nile blue derivative is adopted as a fluorophore and alanyl is adopted as an identification unit to design and synthesize the ratiometric fluorescent probe NB-APN for detecting APN. After the probe reacts with APN, the NB blocked by alanyl is released, resulting in an increase of a fluorescence peak at 675 nm and a decrease of a fluorescence peak at 610 nm. A ratio signal of the probe exhibits a sensitive response to APN, with a detection limit as low as 15 pg/mL. The probe can be used for quantitative detection of APN in a diluted urine sample, and can also be used for ratiometric fluorescent imaging of APN in a cell model and in vivo fluorescent imaging of APN in a nude mouse tumor model.
Opening claim text (preview).
What is claimed is: 1 . A ratiometric fluorescent probe for detecting aminopeptidase N, wherein a structure of the ratiometric fluorescent probe comprises an alanyl group and a Nile blue derivative; wherein the Nile blue derivative has a structural formula as follows: wherein the ratiometric fluorescent probe has a structural formula as follows: 2 . The ratiometric fluorescent probe according to claim 1 , wherein in the structure of the ratiometric fluorescent probe, a quantity ratio of the alanyl group to the Nile blue derivative is 1:1. 3 . A kit for fluorometric analysis of aminopeptidase N in a body fluid or fluorescent imaging of aminopeptidase N in a cell comprising the ratiometric fluorescent probe according to claim 1 . 4 . The kit for fluorescent imaging of aminopeptidase N in a cell according to claim 3 , wherein the cell comprises a human normal cell and a human tumor cell. 5 . The kit for fluorometric analysis of aminopeptidase N in a body fluid according to claim 3 , wherein in the structure of the ratiometric fluorescent probe, a quantity ratio of the alanyl group to the Nile blue derivative is 1:1.
acting on peptide bonds (3.4) · CPC title
with fluorescent label · CPC title
Spatial resolved fluorescence measurements; Imaging · CPC title
for enzymes or isoenzymes · CPC title
with oxygen · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.